Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3200 of 3284 entries
View as:

Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone

Phase: N/A Priority: Normal
NCT ID: NCT02284893 Org: User:
Start: 09/09/14 End: 09/20/16 Due: 09/20/17

A Study of the Efficacy and Safety of MEDI7352 in Participants With Painful Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT04675034 Org: User:
Start: 12/02/20 End: 08/16/23 Due: 08/16/24

Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00663260 Org: User:
Start: 06/30/08 End: 06/30/11 Due: 06/30/12

Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)

Phase: N/A Priority: Normal
NCT ID: NCT04724837 Org: User:
Start: 04/28/21 End: 06/01/23 Due: 06/01/24

BENEFITS OF ACLIDINIUM BROMIDE IN THE RELIEF OF COPD SYMPTOMS INCLUDING COUGH

Phase: N/A Priority: Normal
NCT ID: NCT02375724 Org: User:
Start: 03/31/15 End: 11/30/15 Due: 11/30/16

Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04330040 Org: User:
Start: 05/25/20 End: 09/30/22 Due: 09/30/23

GALLANT 6 Tesaglitazar vs. Pioglitazone

Phase: N/A Priority: Normal
NCT ID: NCT00214565 Org: User:
Start: 08/31/04 End: 10/31/06 Due: 10/31/07

AZD6088 Single Ascending Dose Study

Phase: N/A Priority: Normal
NCT ID: NCT00931541 Org: User:
Start: 06/30/09 End: 08/31/09 Due: 08/31/10

Study of AZD9150 and MEDI4736 (Durvalumab) in Japanese Adult Patients With Advanced Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03394144 Org: User:
Start: 01/30/18 End: 04/12/19 Due: 04/12/20

A Study to Investigate the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel When Given Alone and in Combination With Baxdrostat in Healthy Females of Non-childbearing Potential

Phase: N/A Priority: Normal
NCT ID: NCT06657105 Org: User:
Start: 11/01/24 End: 02/03/25 Due: 02/03/26

The Prevalence, Disease Burden and Prognosis of COPD in Patients With Cardiovascular Diseases

Phase: N/A Priority: Normal
NCT ID: NCT06909773 Org: User:
Start: 05/31/25 End: 02/28/26 Due: 02/28/27

Evaluation in Real World of Molecular Testing and Treatment Patterns for EGFR Mutation in Lung Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03721289 Org: User:
Start: 11/29/18 End: 03/09/19 Due: 03/09/20

Study to Evaluate Methods That Assess the Effect of AZD4017 in Adipose Tissue

Phase: N/A Priority: Normal
NCT ID: NCT01096004 Org: User:
Start: 03/31/10 End: 05/31/10 Due: 05/31/11

Evaluation of Dapagliflozin Taken Twice-daily

Phase: N/A Priority: Normal
NCT ID: NCT01217892 Org: User:
Start: 11/30/10 End: 08/31/11 Due: 08/31/12

A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.

Phase: N/A Priority: Normal
NCT ID: NCT01704495 Org: User:
Start: 11/30/12 End: 08/31/14 Due: 08/31/15

Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study

Phase: N/A Priority: Normal
NCT ID: NCT00255463 Org: User:
Start: 01/31/04 End: 11/30/05 Due: 11/30/06

Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.

Phase: N/A Priority: Normal
NCT ID: NCT00287534 Org: User:
Start: 11/30/96 End: 09/30/04 Due: 09/30/05

Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Disease Modifying Anti-rheumatic Drug (DMARD) But Not Responding.

Phase: N/A Priority: Normal
NCT ID: NCT01197534 Org: User:
Start: 09/30/10 End: 03/31/13 Due: 03/31/14

Ropivacaine Versus Bupivacaine for Spinal Anaesthesia in Patients Undergoing Unilateral Lower Limb Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00358280 Org: User:
Start: 04/30/06 End: 09/30/06 Due: 09/30/07

A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants With Severe Renal Impairment, End-stage Kidney Disease, and in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06693765 Org: User:
Start: 11/18/24 End: 04/23/25 Due: 04/23/26

Study to Assess the Safety and Tolerability After Multiple Oral Doses of AZD1656 in Patients With Type 2 Diabetes Mellitus Treated With Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00817778 Org: User:
Start: 01/31/09 End: 07/31/09 Due: 07/31/10

OSCA - Olaparib Standard of CAre Study

Phase: N/A Priority: Normal
NCT ID: NCT02262273 Org: User:
Start: 10/31/14 End: 04/30/16 Due: 04/30/17

Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT

Phase: N/A Priority: Normal
NCT ID: NCT00646321 Org: User:
Start: 04/30/03 End: 08/31/04 Due: 08/31/05

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124)

Phase: N/A Priority: Normal
NCT ID: NCT00297102 Org: User:
Start: 02/28/06 End: 09/30/08 Due: 09/30/09

Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Preserved)

Phase: N/A Priority: Normal
NCT ID: NCT00634712 Org: User:
Start: 06/30/99 End: 05/31/03 Due: 05/31/04